UPSA Highlights Non-Hormonal Menopause Supplement Research

The company showcases clinical data for its Pure CyTonin pollen extract for menopausal symptom relief.

Updated on Oct. 29, 2026 in Women’s Health

Bold vector editorial illustration showing a stylized botanical pollen structure and wildflower petals, representing natural health supplement research.
UPSA has released clinical research results for its Pure CyTonin pollen extract, designed to help manage menopause symptoms like hot flashes. AI Illustration. Upload story photo >

Live Poll

Do you trust non-hormonal supplements to effectively manage your menopause symptoms?

UPSA is presenting research on FEM Meno, a dietary supplement formulated with purified cytoplasmic pollen extract known as Pure CyTonin. The product is intended to assist with common menopause symptoms like hot flashes and night sweats.

Why it matters

Managing menopausal symptoms remains a significant health need, as approximately 80 percent of women experience hot flashes and night sweats during this life stage. Non-hormonal alternatives are particularly relevant for breast cancer survivors who cannot utilize hormone therapy.

A 2021 study involving 90 women with surgical menopause showed symptom reduction in 88.9 percent of users. Additionally, a 2015 laboratory study indicated that the pollen extract had minimal impact on the CYP2D6 enzyme.

The players

UPSA

Founded in France in 1935, this pharmaceutical company specializes in health and wellness products.

Sérélys Pharma

This company was acquired by UPSA in 2024 to expand its range of specialized health solutions.

The details

The supplement is manufactured by removing the outer shell of pollen grains while preserving the interior material. In clinical settings, the extract has been co-administered with tamoxifen to support survivors of breast cancer.

Timeline

  1. 2021: Pollen extract study on surgical menopause conducted.

  2. 2024: UPSA acquired Sérélys Pharma.

  3. 2024: Study on breast cancer survivors conducted.

  4. November 6-8, 2026: Survival Skills for Women's Health event.

Health Landscape

This research follows the pattern set by the Survival Skills for Women's Health event in bridging the gap between laboratory study and clinical practice. It reflects a broader shift toward investigating non-hormonal solutions for women navigating post-cancer care.

Patients seeking non-hormonal symptom relief may find this extract to be a viable consideration alongside their existing treatment plans. Individuals should consult with their healthcare provider to discuss how such supplements interact with current medications like tamoxifen.

The takeaway

Patients navigating menopause, especially those with a history of breast cancer, have an increasing number of non-hormonal options to discuss with their doctors. Always prioritize clinical evidence and professional medical advice when adding new supplements to your daily health routine.

What happens next

UPSA is scheduled to present its research findings at the Survival Skills for Women's Health event occurring from November 6-8, 2026.

Further reading

Learn more about evolving treatment options in the Women’s Health section.

Source note: This article includes information reported by The Manila times.

Live Poll

Do you trust non-hormonal supplements to effectively manage your menopause symptoms?